- $11.40bn
- $12.55bn
- $30.35bn
- 87
- 74
- 97
- 98
C2019 March 31st | C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 26,211 | 24,210 | 24,124 | 26,041 | 30,346 |
Cost of Revenue | |||||
Gross Profit | 1,617 | 1,529 | 1,775 | 1,947 | 2,288 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 25,854 | 23,884 | 23,262 | 24,844 | 29,162 |
Operating Profit | 357 | 326 | 862 | 1,197 | 1,184 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 182 | 159 | 714 | 1,045 | 974 |
Provision for Income Taxes | |||||
Net Income After Taxes | 93 | 88 | 613 | 940 | 1,033 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 93 | 88 | 613 | 936 | 793 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 93 | 88 | 613 | 936 | 793 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.569 | 0.724 | 1.44 | 1.73 | 1.78 |